Next Article in Journal
Protein Kinases as Drug Development Targets for Heart Disease Therapy
Next Article in Special Issue
Rational Polytherapy with Antiepileptic Drugs
Previous Article in Journal
Role of Non-Steroidal Anti-Inflammatory Drugs in Gynecology
Previous Article in Special Issue
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
Open AccessReview

Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development

Institute of Neurophysiology, Charité Berlin Medical University, Tucholskystrasse 2, D-10117 Berlin, Germany
Pharmaceuticals 2010, 3(7), 2090-2110;
Received: 10 June 2010 / Revised: 28 June 2010 / Accepted: 2 July 2010 / Published: 5 July 2010
(This article belongs to the Special Issue Antiepileptic Drugs)
Epilepsy is a serious neurological disorder that affects around 50 million people worldwide. Almost 30% of epileptic patients suffer from pharmacoresistance, which is associated with social isolation, dependent behaviour, low marriage rates, unemployment, psychological issues and reduced quality of life. Currently available antiepileptic drugs have a limited efficacy, and their negative properties limit their use and cause difficulties in patient management. Antiepileptic drugs can provide only symptomatic relief as these drugs suppress seizures but do not have ability to cure epileptogenesis. The long term use of antiepileptic drugs is limited due to their adverse effects, withdrawal symptoms, deleterious interactions with other drugs and economic burden, especially in developing countries. Furthermore, some of the available antiepileptic drugs may even potentiate certain type of seizures. Several in vivo and in vitro animal models have been proposed and many new antiepileptic drugs have been marketed recently, but large numbers of patients are still pharmacoresistant. This review will highlight the difficulties in treatment and management of epilepsy and the limitations of available antiepileptic drugs and animal seizure models. View Full-Text
Keywords: antiepileptic; anticonvulsant; seizure; pharmacoresistance; refractory seizures antiepileptic; anticonvulsant; seizure; pharmacoresistance; refractory seizures
MDPI and ACS Style

Wahab, A. Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development. Pharmaceuticals 2010, 3, 2090-2110.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop